Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein DLX-3 (encoded by the DLX3 gene) is a transcription factor belonging to the distal-less homeobox family. DLX3 contains a homeobox DNA-binding domain and regulates expression of genes essential for differentiation and development of hair follicles, teeth, and bone. Its transcriptional activity is modulated by Wnt and BMP signaling pathways. Mutations in DLX3 are associated with autosomal dominant disorders affecting hair, teeth, and bone, such as trichodentoosseous syndrome and amelogenesis imperfecta with taurodontism. The protein plays a key role in embryonic development, tissue-specific gene activation, and cellular differentiation[1][2][3][4].
Drugs (if developed) would likely modulate transcriptional activation or DNA-binding activity, but no explicit drug mechanism detailed in results[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein DLX-3 (DLX3).